Anna Janss
- Department of Pediatrics
Professor
- (404) 785-3240
- ajanss@emory.edu
- Children's Healthcare of Atlanta
-
Children's Medical Office Building at Scottish Rite Hospital
Aflac Cancer and Blood Disorders Center
5461 Meridian Mark Road
Academic Appointment
- Associate Professor of Pediatrics, Emory University
Education
Degrees
- DO from University of Iowa
- BA from University of Notre Dame
Research
Focus
- Trained in neuroscience, pharmacology, neurology and pediatric oncology My research goal is to find more effective and less toxic ways to cure children with brain tumors. I have worked in the laboratory to study tumor biology, signal transduction and cell cycle regulation, but currently am committed to clinical ant translational experimental therapeutics.
Publications
-
REMISSION OF HYPOTHALAMIC OBESITY IN PEDIATRIC-ONSET CRANIOPHARYNIOMA DURING INTERFERON-BASED TUMOR TREATMENT
Volume: 69 Page(s): S296 - S297
11/01/2022 Authors: Patterson B; Gray R; Mazewski C; Aguilera D; Craig R; Patil P; Janss A -
CEREBROVASCULAR ACCIDENTS IN PATIENTS WITH CRANIOPHARYNGIOMA. CEREBROVASCULAR ACCIDENTS IN PATIENTS WITH CRANIOPHARYNGIOMA
Volume: 69 Page(s): S285 - S285
11/01/2022 Authors: Patil P; Gray R; Janss A; Aguiera D; Brahma B; Wrubel D; Chern J; Goldman-Yassen A; Wolf D; Esiashvili N -
THE USE OF SUBCUTANEOUS INTERFERON IN PATIENTS WITH CRANIOPHARYNGIOMA: AN INSTITUTIONAL RETROSPECTIVE REVIEW
Volume: 24 Page(s): 15 - 16
06/01/2022 Authors: Patil P; Gray R; Goldman-Yassen A; Aguilera D; Castellino R; Janss A; Mazewski C -
RADIATION INDUCED MALIGNANCY ASSOCIATED WITH PEDIATRIC CRANIOPHARYNGIOMA: A SINGLE INSTITUTION EXPERIENCE
Volume: 24 Page(s): 16 - 16
06/01/2022 Authors: Chien F; Schniederjan M; Castellino RC; Janss A; Esiashvili N; Eaton B; Indelicato D; Mazewski C -
A PHASE II STUDY OF PEGYLATED INTERFERON IN CHILDREN WITH RECURRENT OR REFRACTORY AND RADIOGRAPHICALLY OR CLINICALLY PROGRESSIVE JUVENILE PILOCYTIC ASTROCYTOMAS AND OPTIC PATHWAY GLIOMAS (NCT02343224)
Volume: 24 Page(s): 103 - 103
06/01/2022 Authors: Aguilera D; Mazewski C; Janss A; MAcDonald T; Goldman A; Leong T; Castellino RC -
Long-Term Outcomes for Children with Atrt Treated with Intensive Multimodal Therapy: An Update on DFCI #02-294
Volume: 68 Page(s): S116 - S116
11/01/2021 Authors: Rosenberg T; Zimmerman MA; Fisher M; Fangusaro J; Cohen K; Janss A; Bowers D; Bendel A; Goldman S; Manley P -
Vision-related quality-of-life in pediatric primary brain tumor patients.
J Neurooncol Volume: 154 Page(s): 365 - 373
09/01/2021 Authors: Peragallo JH; Bruce BB; Vasseneix C; Jariyakosol S; Janss AJ; Newman NJ; Biousse V -
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
J Clin Oncol Volume: 39 Page(s): 2685 - 2697
08/20/2021 Authors: Michalski JM; Janss AJ; Vezina LG; Smith KS; Billups CA; Burger PC; Embry LM; Cullen PL; Hardy KK; Pomeroy SL -
Impact of executive functioning on health-related quality of life of pediatric brain tumor survivors.
Pediatr Blood Cancer Volume: 68 Page(s): e29130
08/01/2021 Authors: Murphy C; Upshaw NC; Thomas AS; Fong G; Janss A; Mazewski C; Ingerski LM -
Cervicomedullary Astroblastoma with EWSR1-BEND2 Fusion: Expanding the Molecular Heterogeneity of Astroblastomas and the HGNET-MN1 Methylation Class Family
Volume: 101 Page(s): 1032 - 1033
03/01/2021 Authors: Vega JV; Janss A; Boydston W; Bridge J; Snuderl M; Schniederjan M